跳至主要内容
临床试验/NCT05101733
NCT05101733Unknown不适用

Pilot Study Regarding Mold Allergy in Austria: Clinical Relevance of Alternaria Alternata and Related Species

Medical University of Vienna1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2021年10月14日最近更新:
适应症

试验速览

阶段
不适用
入组人数
70
试验地点
1
主要终点
Prevalence, Immunoglobulin-E (IgE)-antibodies to selected Alternaria species

研究概览

简要总结

Mold allergies are becoming increasingly important among the population. Increasing amounts of fungal spores are analyzed in air-samples because of urbanization, industrialization of food products and climate change. Mold also grows indoor and hence lead to additional health complaints.

Alternaria alternata, and its only major allergen Alt a 1, is the most important fungus for allergy sufferers. Alternaria alternata can not only cause allergic symptoms but can also cause intensified asthmatic symptoms.

Besides Alternaria alternata, there are over 700 other species of the genus Alternaria. The influence of these other species on allergic symptoms is poorly understood.

Furthermore, prevalence and incidence of an allergy to Alternaria alternata among the Austrian population is not known. Estimates range between 1-5% among the Austrian population.

This study aims to further investigate the incidence and characteristics of an allergy to Alternaria in Austria. This will be investigated with the help of participants (50 Alternaria allergy sufferers and 20 non allergic participants), spore counts in Austria and crowd-sourced symptom data.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Participants will be healthy people over 18 years of age. Allergic participants should have an allergic reaction against Alternaria, visible in the Skin-Prick-Test. Furthermore symptom data in the pollen diary of the Austrian Pollen Information Service should be existing

排除标准

  • Subjects participating in a pharmacological study, pregnant subjects and subjects with an existing infectious- and/or autoimmune disease

结局指标

主要结局

Prevalence, Immunoglobulin-E (IgE)-antibodies to selected Alternaria species

时间窗: 12 months

Determine the prevalence of sensitization to multiple Alternaria species in the Austrian population

次要结局

  • Cytokine-profile (e.g. Interleukin-13, Interleukin-5, Interleukin-10, TNFalpha, IFNgamma) upon Alt a 1 incubation(12 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. Markus Berger

Dr. med. univ.

Medical University of Vienna

研究点 (1)

Loading locations...

相似试验